NO971037D0 - Trifenyletylener til beskyttelse mot behandling av osteoporose - Google Patents

Trifenyletylener til beskyttelse mot behandling av osteoporose

Info

Publication number
NO971037D0
NO971037D0 NO971037A NO971037A NO971037D0 NO 971037 D0 NO971037 D0 NO 971037D0 NO 971037 A NO971037 A NO 971037A NO 971037 A NO971037 A NO 971037A NO 971037 D0 NO971037 D0 NO 971037D0
Authority
NO
Norway
Prior art keywords
pct
triphenylethylenes
protect against
osteoporosis treatment
against osteoporosis
Prior art date
Application number
NO971037A
Other languages
English (en)
Other versions
NO971037L (no
NO315785B1 (no
Inventor
Michael Degregorio
Lauri Veikko Matti Kangas
Pirkko Haerkoenen
Kalervo Vaeaenaenen
Aire Laine
Valerie Wiebe
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO971037D0 publication Critical patent/NO971037D0/no
Publication of NO971037L publication Critical patent/NO971037L/no
Publication of NO315785B1 publication Critical patent/NO315785B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Materials For Photolithography (AREA)
NO19971037A 1994-09-07 1997-03-06 Trifenyletylener til beskyttelse mot og behandling av osteoporose NO315785B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9418067A GB9418067D0 (en) 1994-09-07 1994-09-07 Triphenylethylenes for the prevention and treatment of osteoporosis
PCT/FI1995/000475 WO1996007402A1 (en) 1994-09-07 1995-09-06 Triphenylethylenes for the prevention and treatment of osteoporosis

Publications (3)

Publication Number Publication Date
NO971037D0 true NO971037D0 (no) 1997-03-06
NO971037L NO971037L (no) 1997-04-29
NO315785B1 NO315785B1 (no) 2003-10-27

Family

ID=10761007

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971037A NO315785B1 (no) 1994-09-07 1997-03-06 Trifenyletylener til beskyttelse mot og behandling av osteoporose

Country Status (17)

Country Link
US (2) US5750576A (no)
EP (1) EP0779808B1 (no)
JP (1) JP3910211B2 (no)
AT (1) ATE183389T1 (no)
CA (1) CA2198389C (no)
DE (1) DE69511566T2 (no)
DK (1) DK0779808T3 (no)
ES (1) ES2135083T3 (no)
FI (1) FI118755B (no)
GB (1) GB9418067D0 (no)
GR (1) GR3031109T3 (no)
IL (1) IL115171A (no)
NO (1) NO315785B1 (no)
NZ (1) NZ291836A (no)
SI (1) SI0779808T1 (no)
WO (1) WO1996007402A1 (no)
ZA (1) ZA957481B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
GB9609171D0 (en) 1996-05-02 1996-07-03 Orion Yhtymae Oy Antioxidant compounds
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
GB9803521D0 (en) * 1998-02-19 1998-04-15 Orion Yhtymo Oy New compounds and pharmaceutical compositions thereof
US20040186185A1 (en) * 1998-05-07 2004-09-23 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
TW593256B (en) 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
SI1235776T1 (sl) * 1999-11-16 2006-06-30 Hormos Medical Corp Trifenilalkenski derivati in njihova uporaba kot selektivni estrogenski receptorski modulatorji
US6245819B1 (en) 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US20040214898A1 (en) * 2001-11-29 2004-10-28 Steiner Mitchell S. Methods for treating hot flashes
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
US8236861B2 (en) * 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US20050187302A1 (en) * 2004-02-23 2005-08-25 Hormos Medical Corporation Method for treatment or prevention of osteoporosis in individuals with high bone turnover
US8642079B2 (en) 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
CN1950071A (zh) 2004-05-04 2007-04-18 霍尔莫斯医疗有限公司 ospemifene的新口服制剂
US20060293294A1 (en) * 2004-09-03 2006-12-28 Hormos Medical Corporation Method for treatment or prevention of androgen deficiency
US20060270641A1 (en) * 2005-05-31 2006-11-30 Steiner Mitchell S Method for chemoprevention of prostate cancer
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8637706B2 (en) 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US8158828B2 (en) 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
KR101505884B1 (ko) 2006-05-22 2015-03-25 호르모스 메디칼 리미티드 만성 비세균성 전립선염 치료용 선택적 에스트로겐 수용체 조절제 또는 아로마타아제 저해제
US20080176255A1 (en) * 2007-01-23 2008-07-24 Edward Sobek Mold detection composition and methods
WO2008099060A2 (en) * 2007-02-14 2008-08-21 Hormos Medical Ltd Methods for the preparation of fispemifene from ospemifene
SI2121553T1 (sl) 2007-02-14 2012-11-30 Hormos Medical Ltd Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov
WO2008157335A2 (en) 2007-06-13 2008-12-24 Quatrx Pharmaceuticals Company Methods for the treatment of erectile dysfunction using fispemifene
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
KR101149529B1 (ko) 2009-09-11 2012-05-25 한국화학연구원 인덴온 유도체 및 이를 포함하는 약학적 조성물
EP2526080B1 (en) * 2010-01-19 2014-03-26 Cambrex Karlskoga AB New processes for producing benzophenone derivatives
US9321712B2 (en) 2012-10-19 2016-04-26 Fermion Oy Process for the preparation of ospemifene
WO2014060640A1 (en) 2012-10-19 2014-04-24 Fermion Oy A process for the preparation of ospemifene
CN103739456A (zh) * 2013-12-03 2014-04-23 镇江圣安医药有限公司 2-（对-（（z-4-氯-1,2-二苯基-1-丁烯基）苯氧基）乙醇的新型衍生物及其应用
US9975832B2 (en) 2014-12-29 2018-05-22 Olon S.P.A. Process for the preparation of ospemifene and fispemifene
US10138190B2 (en) 2015-01-09 2018-11-27 Glenmark Pharmaceuticals Limited Process for preparation of ospemifene
WO2016145138A1 (en) 2015-03-10 2016-09-15 Shionogi Inc. Solid dispersions
KR102052133B1 (ko) * 2017-08-10 2019-12-05 고려대학교 산학협력단 당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
GR1009542B (el) 2018-04-25 2019-06-07 Φαρματεν Α.Β.Ε.Ε. Καψουλα μαλακης γελης που περιλαμβανει εναν εκλεκτικο ρυθμιστη οιστρογονικων υποδοχεων
KR20220115062A (ko) 2021-02-09 2022-08-17 (주)오스티오뉴로젠 크로몬 구조의 화합물을 포함하는 골다공증의 예방 및 치료용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites

Also Published As

Publication number Publication date
EP0779808A1 (en) 1997-06-25
FI118755B (fi) 2008-03-14
JP3910211B2 (ja) 2007-04-25
EP0779808B1 (en) 1999-08-18
ZA957481B (en) 1996-04-09
US5750576A (en) 1998-05-12
GB9418067D0 (en) 1994-10-26
WO1996007402A1 (en) 1996-03-14
CA2198389A1 (en) 1996-03-14
ES2135083T3 (es) 1999-10-16
FI970920A (fi) 1997-03-04
NO971037L (no) 1997-04-29
GR3031109T3 (en) 1999-12-31
AU3347895A (en) 1996-03-27
JPH10505079A (ja) 1998-05-19
IL115171A (en) 2001-08-26
ATE183389T1 (de) 1999-09-15
AU699845B2 (en) 1998-12-17
SI0779808T1 (en) 1999-10-31
DE69511566T2 (de) 2000-04-27
IL115171A0 (en) 1995-12-31
CA2198389C (en) 2007-02-20
DE69511566D1 (de) 1999-09-23
NZ291836A (en) 1998-06-26
DK0779808T3 (da) 2000-03-13
NO315785B1 (no) 2003-10-27
US5912273A (en) 1999-06-15
FI970920A0 (fi) 1997-03-04

Similar Documents

Publication Publication Date Title
NO971037D0 (no) Trifenyletylener til beskyttelse mot behandling av osteoporose
PL318297A1 (en) Dihydrobenzofuranes
PL313821A1 (en) Analogues of distamycin a as anticarcinogenic and antiviral agents
ZA959516B (en) Use of dioxomorpholines for combating endoparasites new dioxomorpholines and processes for their preparation
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
TW263499B (no)
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
GB9423914D0 (en) Polyether derivatives as metalloproteinase inhibitors
HU9700024D0 (en) Imidazopyridin-azolidinones
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GB9507883D0 (en) Compounds
HU9601381D0 (en) Substituted aminoalkylaminopyridines
HK1024872A1 (en) Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia

Legal Events

Date Code Title Description
MK1K Patent expired